T1	Participants 69 96	premenopausal breast cancer
T2	Participants 699 738	premenopausal women with breast cancer.
T3	Participants 859 940	500 available tumour specimens from 564 premenopausal patients with breast cancer
T4	Participants 1863 1891	patients with breast cancer.
